2,089.00 
2.00(0.10%) 23:29 SGT
| Prev Close: | 2,087.00 |
|---|
| Open: | 2,081.00 |
|---|
| Bid: | 2,087.00 |
|---|
| Ask: | 2,091.00 |
|---|
| 1y Target Est: | 37.71 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 2,059.00 - 2,098.00 |
|---|
| 52wk Range: | 1,682.00 - 2,235.00 |
|---|
| Volume: | 1,543,421 |
|---|
| Avg Vol (3m): | 1,826,840 |
|---|
| Market Cap: | 11.52B |
|---|
| P/E (ttm): | 2,048.04 |
|---|
| EPS (ttm): | 1.02 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in GBp.
Headlines
- Nominate a Non-professional Caregiver for International BRAVE Awards through June 30PR Newswire(Fri, 14 Jun)
- Shire to Present at the Goldman Sachs 34th Annual Global Healthcare ConferencePR Newswire(Tue, 11 Jun)
- Shire to Present at the Goldman Sachs 34th Annual Global Healthcare ConferencePR Newswire(Tue, 11 Jun)
- Tax leverage helps make Irish pharma a popular targetReuters(Tue, 11 Jun)
- DEALTALK-Tax leverage helps make Irish pharma a popular targetat Reuters(Tue, 11 Jun)
- Shire’s New CEO Adds Sales Staff, Damps Takeover Talkat Bloomberg(Tue, 11 Jun)
- Questcor names former Shire CEO to boardAP(Mon, 10 Jun)
- Questcor names former Shire CEO to boardAP(Mon, 10 Jun)
- Share price windfall reignites debate over executive payat Financial Times(Mon, 10 Jun)
- 10 FTSE 100 Shares Trading Near 52-Week Highsat Motley Fool(Tue, 4 Jun)
Key Statistics
| Forward P/E (1 yr): | 8.32 |
|---|
| P/S (ttm): | 246.39 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 2.22 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.56 |
|---|
| Mean Recommendation*: | 2.1 |
|---|
| PEG Ratio (5 yr expected): | 1.62 |
|---|
Business Summary
Shire plc, a specialty biopharmaceutical company, engages in the research and development, manufacture, sale, and distribution of pharmaceutical products.
View More